Peter Rieckmann MD

Dr. Peter Rieckmann received his MD from the University of Göttingen in 1998. After a postdoctoral fellowship in Molecular Immunology at the NIH, Bethesda, USA, he completed his training in Neurology at the National Institute for Nervous Disease, London, UK and the University of Göttingen, Germany. He was Head of the Clinical Research Group for Multiple Sclerosis and Neuroimmunology at the Julius-Maximilians University of Würzburg and holds several positions as visiting Professor across the globe. In 2000, Professor Rieckmann became the MS Society of Canada Research Chair and Director of the MS Program at the University of British Columbia and Vancouver Hospital, Canada
Dr. Reickmann’s major research interests are disease-modifying factors and regeneration in MS as well as functional aspects of the blood brain barrier in neuroimmunological diseases. Professor Rieckmann’s clinical goals include enhancing awareness and education about MS, developing effective and properly resourced services for MS outpatient care, and providing more customized treatments for patients. He is chairman of the MS in the 21st century steering group, an international MS stakeholder initiative. He serves on steering committees of various international multicenter MS trials (Phase II and III). Professor Rieckmann is a Fellow of the Royal College of Physicians and Surgeons, Canada and has over 200 papers to his credit in peer-reviewed medical journals.